Fig. 3From: Recurrent gastric cancer sustaining a partial response after the nivolumab discontinuation because of immune-related adverse events: a case reportAfter three courses of ramucirumab + paclitaxel, the size of the metastatic lymph node was 58 mm × 57 mm (arrow)Back to article page